Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice-Reference-Cited by-同舟云学术

Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice

Published:1999-08-31 Issue:18 Volume:96 Page:10379-10384
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

VandenDriessche T.,Vanslembrouck V.,Goovaerts I.,Zwinnen H.,Vanderhaeghen M.-L.,Collen D.,Chuah M. K. L.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference40 articles.

1. Gene Therapy for Hemophilia A

2. Gene therapy for hemophilia: hopes and hurdles

3. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

4. Development and Analysis of Retroviral Vectors Expressing Human Factor VIII as a Potential Gene Therapy for Hemophilia A

5. Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer.

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrasound-mediated gene delivery specifically targets liver sinusoidal endothelial cells for sustained FVIII expression in hemophilia A mice;Molecular Therapy;2024-04

2. Strategies for Hemophilia Treatment, a literature review of current evidence;Journal of Birjand University of Medical Sciences;2023-12-01

3. Recent Advances in In Vivo Somatic Cell Gene Modification in Newborn Pups;International Journal of Molecular Sciences;2023-10-18

4. Hemophilia Gene Therapy: The End of the Beginning?;Human Gene Therapy;2023-09-01

5. Gene modification therapies for hereditary diseases in the fetus;Prenatal Diagnosis;2023-04-05